Background: Previous studies have identified that diabetics have higher mortality and receive less evidence based medicine (EBM) following an Acute Coronary Syndrome (ACS) than non-diabetics. We wanted to assess EBM and outcomes in contemporary cardiovascular practice.
|Number of pages||1|
|Journal||Heart, Lung and Circulation|
|Issue number||Supp 2|
|Publication status||Published - 1 Jan 2007|